Elaine Wu

Elaine Wu is an accomplished biostatistician with extensive experience in the pharmaceutical industry, currently serving as Director at both Roivant Sciences and Hemavant Sciences since July 2022. Prior to these roles, Elaine held the position of Director at Daiichi Sankyo, Inc. from April 2021 to July 2022 and served as Associate Director at Bayer from September 2017 to April 2021. Elaine's career began at Novartis as a Senior Principal Biostatistician from May 2013 to September 2017, and Elaine was a Senior Biostatistician at Vertex Pharmaceuticals from April 2012 to May 2013. Elaine holds a PhD in Statistics from Northwestern University, completed in 2011, and a Bachelor's degree from Tsinghua University.